The following is excerpted from the deposition of Dr. Peter S. Kim, president of Merck Research Laboratories, in the national Vioxx litigation. In his testimony, Kim acknowledges his failure to report adverse reactions among patients who used Vioxx to the U.S. Food and Drug Administration (FDA). He also tells of his own mother’s use of Vioxx – and that she stopped taking the medication after he informed her of its impending recall. Questioning Kim for the plaintiffs is Shanin Specter of Kline & Specter, PC.
June 8, 2005 (read full excerpt from transcript below video)